netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

RPB AWARDS $5.4 MILLION IN GRANTS

Research to Prevent Blindness (RPB) awarded 27 grants totaling $5.4 million during its Fall 2016 grant cycle. The latest awards include unrestricted grants to departments of ophthalmology at 17 medical schools across the United States and 10 awards to individual scientists.

RPB currently funds research at 40 medical institutions throughout the U.S., where RPB-supported laboratories investigate the entire spectrum of eye disease, from cataracts, glaucoma, and diabetic retinopathy to macular degeneration, retinitis pigmentosa and eye movement disorders.

Among the newly funded investigations are: the development of animal models of diabetic eye disease to learn how fenofibrate, a drug clinically-approved to treat cholesterol, protects the eye from diabetes-related damage; the development of a specialized camera to capture how the retina's rods and cones (responsible for turning light energy into shapes and colors) work in health and how they fail in retinal diseases; and the exploration of mechanisms by which intestinal tract bacteria impact the health of the eye.

The first Research to Prevent Blindness/Starvos Niarchos Foundation International Research Collaborators Award was awarded to Adam Kohn, PhD, of Albert Einstein College of Medicine in New York City, and his international collaborator, Samuel Solomon, PhD, of University College London. The new Award promotes international collaborations through which researchers in the U.S. and outside the U.S. gain knowledge and skills and enhance each other's work. Drs. Kohn and Solomon seek to examine how feedback signals change the activity of nerve cells in the visual cortex, and thereby influence our capacity to see. 

Since it was founded in 1960, RPB has channeled more than $346 million into eye research.  As a result, RPB has been identified with nearly every major breakthrough in vision research in that time. Learn more about our current and past grantees here.

Related News: Feature Story, Top Story

In Memoriam: John I. Bloomberg

With deep sorrow, Research to Prevent Blindness (RPB) announces the passing of John I. Bloomberg, who served on the RPB Board of Trustees from 2007 to 2017.

Read More

 

Natural Compound Reduces Signs of Aging, Including Eye Dryness

RPB-supported vision researchers at Washington University School of Medicine in St. Louis have contributed key data to a new study that identifies a natural compound that slows typical signs of aging in mice.

Read More

 

Emerging Vision Scientists Visit Capitol Hill

Twenty-two emerging vision scientists conducted Capitol Hill visits with NAEVR and RPB to champion federal funding for critical vision research.

Read More

 

Researchers Identify Treatment Target for Blinding Retinal Diseases

A common pathway involved in photoreceptor death has been identified in retinitis pigmentosa, advanced dry age-related macular degeneration and other retinal diseases, with early evidence of a possible halt to vision loss related to pathway treatment.

Read More

 

New Report Aims to Make Eye Health a Public Health Priority

The National Academies of Sciences, Engineering, and Medicine issues nine concrete recommendations for improving eye and vision health and increasing health equity.

Read More

 

Zika Virus Found in Tears

Researchers publish critical findings from Zika mouse model, raising the possibility of new avenues of transmission, as well as confirming the virus’ ability to induce cell death in eyes.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.